Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055860 · ClinicalTrials.gov registry record
One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review
A clinical trial, sponsored by Atlantic Health System.
- Completed
- Registry status
- 75
- Enrollment target
NCT01055860: Completed study, sponsored by Atlantic Health System.
NCT01055860 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055860 has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Robotic approach to sacral colpopexy is a relatively new procedure. The literature is scarce in regard to its long-term outcomes. This advanced procedure is offered at MMH through the Urogynecology division. The Investigators setup to review the one year outcome of patients who underwent this procedure using a polypropylene mesh. These outcomes will include anatomical and quality of life measures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-07 |
What the finished NCT01055860 record still lists
NCT01055860 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01055860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01055860 about?
NCT01055860 is a clinical study titled "One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review". Robotic approach to sacral colpopexy is a relatively new procedure. The literature is scarce in regard to its long-term outcomes. This advanced procedure is offered at MMH through the Urogynecology division. The Investigators setup to review the one year outcome of patients who underwent this proced...
What is the current status of trial NCT01055860?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2009-02. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT01055860?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia